Chicago Rivet & Machine (CVR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Nov, 2026Executive summary
Q3 2026 sales rose 2.3% YoY to $7.53M, but gross profit fell 49.5% to $672K and results swung to a $916K net loss from $68K net income.
Nine-month sales declined 1.3% YoY to $21.62M; net loss was $2.27M versus $74K net income, with lower volumes, weaker fixed-cost absorption, unfavorable mix and higher costs weighing on results.
Financial highlights
Q3 operating loss was $917K versus $65K operating income YoY; nine-month operating loss was $2.33M versus $57K operating income.
Q3 gross profit was $672K versus $1.33M; nine-month gross profit was $2.19M versus $3.96M.
Q3 diluted loss per share was $0.95 versus $0.07 earnings; nine-month diluted loss per share was $2.35 versus $0.08 earnings.
Nine-month operating cash use was $1.72M; cash and equivalents ended at $634K, down from $1.72M at year-end 2025.
Outlook and guidance
FY 2026 outlook remains subject to macro uncertainty; production volumes in served segments are expected to increase slightly, with new customer awards ramping in Q1 2027.
Automotive demand is expected to improve modestly while non-automotive markets continue to lag; new and existing customer opportunities are expected to show meaningful progress in Q4 2026 and FY 2027.
Priorities include expense reduction, operational efficiency, customer pricing actions, new sales, improved sales mix and active monitoring of tariff impacts.
Latest events from Chicago Rivet & Machine
- Net loss widened and liquidity concerns persist, raising substantial doubt about going concern.CVR
Q2 2026 - Sales and margins declined sharply in Q1 2026, raising substantial going concern risks.CVR
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.CVR
Proxy filing - Substantial doubt remains about going concern status despite improved margins and narrowed losses.CVR
Q4 2025 - Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 2024 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 2024 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 2024